Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (421-430 of 1,022) with videos related to

Pageof 103
Sort By:
Plos One|January 16, 2020
Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-studyFinlay A McAlister, Rajibul Mian, Jonas Oldgren, et al.
Current Cardiovascular Risk Reports|June 28, 2021
Feasibility of Incorporating Voice Technology and Virtual Assistants in Cardiovascular Care and Clinical TrialsPishoy Gouda, Elie Ganni, Peter Chung, et al.
Journal of the American College of Cardiology|October 19, 2004
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery diseaseJustin Ezekowitz, Finlay A McAlister, Karin H Humphries, et al.
Nature|May 9, 1991
Uptake of Pneumocystis carinii mediated by the macrophage mannose receptorR A Ezekowitz, D J Williams, H Koziel, et al.
American Heart Journal|August 10, 2010
Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) SubstudyJustin A Ezekowitz, Paul W Armstrong, Christopher B Granger, et al.
American Heart Journal|October 12, 2010
Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) TrialMustafa Toma, Yuling Fu, Justin A Ezekowitz, et al.
Circulation|December 15, 1996
Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibodyR K Aggarwal, D C Ireland, M A Azrin, et al.
Progress in Clinical and Biological Research|January 1, 1990
Comparison of platelet scintigraphy, impedance plethysmography gray scale and color flow duplex ultrasound and venography for the diagnosis of venous thrombosisM D Ezekowitz, F Migliaccio, D Farlow, et al.
Journal of the American College of Cardiology|February 25, 2012
Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) studyGreg Flaker, Michael Ezekowitz, Salim Yusuf, et al.
Biochemical and Biophysical Research Communications|April 1, 2006
Characterization of an equine mannose-binding lectin and its roles in diseaseMichael J Podolsky, Aaron Lasker, M Julia B F Flaminio, et al.
Pageof 103

Showing results (421-430 of 1,022) with videos related to

Sort By:
Pageof 103
Plos One|January 16, 2020
Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-studyFinlay A McAlister, Rajibul Mian, Jonas Oldgren, et al.
Current Cardiovascular Risk Reports|June 28, 2021
Feasibility of Incorporating Voice Technology and Virtual Assistants in Cardiovascular Care and Clinical TrialsPishoy Gouda, Elie Ganni, Peter Chung, et al.
Journal of the American College of Cardiology|October 19, 2004
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery diseaseJustin Ezekowitz, Finlay A McAlister, Karin H Humphries, et al.
Nature|May 9, 1991
Uptake of Pneumocystis carinii mediated by the macrophage mannose receptorR A Ezekowitz, D J Williams, H Koziel, et al.
American Heart Journal|August 10, 2010
Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) SubstudyJustin A Ezekowitz, Paul W Armstrong, Christopher B Granger, et al.
American Heart Journal|October 12, 2010
Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) TrialMustafa Toma, Yuling Fu, Justin A Ezekowitz, et al.
Circulation|December 15, 1996
Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibodyR K Aggarwal, D C Ireland, M A Azrin, et al.
Progress in Clinical and Biological Research|January 1, 1990
Comparison of platelet scintigraphy, impedance plethysmography gray scale and color flow duplex ultrasound and venography for the diagnosis of venous thrombosisM D Ezekowitz, F Migliaccio, D Farlow, et al.
Journal of the American College of Cardiology|February 25, 2012
Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) studyGreg Flaker, Michael Ezekowitz, Salim Yusuf, et al.
Biochemical and Biophysical Research Communications|April 1, 2006
Characterization of an equine mannose-binding lectin and its roles in diseaseMichael J Podolsky, Aaron Lasker, M Julia B F Flaminio, et al.
Pageof 103